Company Overview and News

 
Forces Of Movement

2018-10-14 seekingalpha
A critical issue for investors is whether the stability ahead of the weekend in US equities signals an end to the downdraft.
9696

 
Market Fever Is Burning Itself Out Ahead Of The Weekend

2018-10-12 seekingalpha
If US stocks are unable to sustain gains today, it would set the stage of a tough start to next week.
9696

18
James Murdoch in line to replace Musk as Tesla chairman, reports FT

2018-10-10 malaymail
LONDON, Oct 11 — Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported yesterday, citing two people briefed on the discussions.
GJV FOX NWSA NWS CCV.CL CCV CMCSA CCZ FOXA 9696 CMCSK DIS

18
James Murdoch tipped to replace Elon Musk as Tesla chairman

2018-10-10 theage.com.au
Outgoing 21st Century Fox chief executive James Murdoch is the lead candidate to replace Elon Musk as Tesla chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
FOX 9696 FOXA DIS

18
James Murdoch tipped to replace Elon Musk as Tesla chairman

2018-10-10 watoday.com.au
Outgoing 21st Century Fox chief executive James Murdoch is the lead candidate to replace Elon Musk as Tesla chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
FOX 9696 FOXA DIS

18
James Murdoch tipped to replace Elon Musk as Tesla chairman

2018-10-10 smh.com.au
Outgoing 21st Century Fox chief executive James Murdoch is the lead candidate to replace Elon Musk as Tesla chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
FOX 9696 FOXA DIS

18
James Murdoch the lead candidate to replace Elon Musk as Tesla chairman

2018-10-10 theage.com.au
Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
FOX 9696 FOXA DIS

18
James Murdoch the lead candidate to replace Elon Musk as Tesla chairman

2018-10-10 watoday.com.au
Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
FOX 9696 FOXA DIS

18
James Murdoch the lead candidate to replace Elon Musk as Tesla chairman

2018-10-10 smh.com.au
Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
FOX 9696 FOXA DIS

77
A Deeper Look At U.S.-China Trade And Mainland Performance

2018-10-10 seekingalpha
According to the US Census Bureau, the United States imports more cars from Canada than from any other country in the world1. Considering this statistic, you would assume that Canadian car brands like Intermeccanica and Campagna would be household names in the US, but they are not. The US Census Bureau defines imports as "all goods physically brought into the United States…"2; therefore, in reality, the bulk of the Canadian cars referenced in this statistic are Fords, Chevys, and Lincolns assembled in Canadian plants and shipped back to the US.
TSNU F GE WHR GEC NKE WYNN AAPL TSLA GNE TSN 9696

6
Baidu: Value Investors To Step In

2018-10-08 seekingalpha
A long runway for growth in China along with access to global markets will result in a much higher share price for Baidu before long.
GOOGL GOOG BIDU 9696

 
EURUSD Drivers And Medium-Term Outlook

2018-10-08 seekingalpha
An interesting long-driver of the EURUSD exchange rate is the natural rate of interest differential (estimated by a version of the Laubach-Williams model).
IR 9696

 
More Yielding To Yields Next Week?

2018-10-06 seekingalpha
What a barn burner of a week!! Fixed income took centre stage, but the lingering odour from risk aversion and choppy intraday moves will continue to challenge traders at every twist and turn.
9696

 
Record US imports drive goods trade deficit with China to high in August

2018-10-05 malaymail
WASHINGTON, Oct 5 ― The US trade deficit ballooned in August to its highest level in six months as exports of tariff-targeted goods fell while American consumers snapped up imported cars and mobile phones, the government reported today.
9696

 
Oh no! Toddler shreds envelope with $1600 of parents' savings

2018-10-04 nzherald.co.nz
A Utah couple were left in tears after their toddler put more than US$1000 of his parents' savings through a shredder.
9696

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...